Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 5/20 | 0.41 |
| ▸ | CBLB | Q13191 | 7/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6174760 | 0.89 | IGF1R (0.41) | IGF1RCBLBNPC1RAB9A | |
| SCHEMBL6175275 | 0.88 | IGF1R (0.41) | IGF1RCBLBNPC1RAB9A | |
| SCHEMBL6177007 | 0.88 | TDP1 (0.42) | CBLB | |
| SCHEMBL6174034 | 0.87 | CBLB (0.36) | IGF1RCBLBNPC1RAB9AALDH1A1 | |
| SCHEMBL6177806 | 0.85 | IGF1R (0.43) | IGF1R | |
| SCHEMBL6176013 | 0.85 | IGF1R (0.41) | IGF1RNPC1RAB9A | |
| SCHEMBL6175915 | 0.83 | IGF1R (0.42) | IGF1R | |
| SCHEMBL6173765 | 0.83 | KCNK2 (0.44) | IGF1RNPC1RAB9AALDH1A1TP53 | |
| SCHEMBL6177584 | 0.83 | IGF1R (0.38) | IGF1R | |
| SCHEMBL6173973 | 0.82 | IGF1R (0.46) | IGF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599464-A2 | NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | Aventis Pharma S.A. (FR) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004070050-A2 | CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | AVENTIS PHARMA S.A. (FR) | 2004-08-19 | — | — | WO | disclosed |